Researchers say the pill, daraxonrasib, works by blocking a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases.
This article was originally published by 9News Colorado (RSS) on Sunday, May 31, 2026. TownPost surfaces local news from over 40 outlets and uses AI to score each story for relevance to Longmont and the surrounding area.
Relevance score: 10/100. This story has regional context that may affect Longmont.
TownPost does not modify or rewrite source content. Read the full article at its original publication for complete coverage.
